Documents
-
ANNUAL REPORT
10-K
-
LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT EFFECTIVE APRIL 9, 2019 BY AND BETWEEN ELITE PHARMACEUTICALS, INC., AND ELITE LABORATORIES, INC. AND LANNETT COMPANY, INC., USA
EX-10.49
-
LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT EFFECTIVE MARCH 6, 2019 BY AND BETWEEN ELITE PHARMACEUTICALS, INC., AND ELITE LABORATORIES, INC. AND LANNETT COMPANY, INC., USA
EX-10.50
-
DEVELOPMENT AGREEMENT EFFECTIVE DECEMBER 3, 2018 BY AND BETWEEN MIKAH PHARMA LLC AND ELITE LABORATORIES, INC. (PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED IN COMPLIANCE WITH REGULATION S-K ITEM 601(B)(10))*
EX-10.51
-
SUBSIDIARY OF THE COMPANY
EX-21
-
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-23.1
-
CERTIFICATION
EX-31.1
-
CERTIFICATION
EX-31.2
-
CERTIFICATION
EX-32.1
-
CERTIFICATION
EX-32.2
-
XBRL INSTANCE FILE
EX-101.INS
-
XBRL SCHEMA FILE
EX-101.SCH
-
XBRL CALCULATION FILE
EX-101.CAL
-
XBRL DEFINITION FILE
EX-101.DEF
-
XBRL LABEL FILE
EX-101.LAB
-
XBRL PRESENTATION FILE
EX-101.PRE
On sec.gov